Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Mario Tiribelli

Associate Professor in Hematology

University of Udine

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (16)

daniela cilloni

PROFESSOR

University of Turin

ITALY

View details

Daniela DAMIANI

University of Udine

ITALY

View details

Antonio Cuneo

Full Professor of Hematology

University of Ferrara

ITALY

View details

Novella Pugliese

Medical assistant

Università degli Studi di Napoli Federico II

ITALY

View details

Valerio De Stefano

Full Professor of Hematology

Università Cattolica del Sacro Cuore

ITALY

View details

Massimiliano BONIFACIO

University of Verona

ITALY

View details

Francesca Palandri

IRCCS Azienda Ospedaliero-Universitaria di Bologna

ITALY

View details

elena rossi

Università Cattolica del Sacro Cuore

ITALY

View details

Giuseppe Alberto Maria PALUMBO

Associate Professor of Hematology

Università degli Studi di Napoli Federico II

ITALY

View details

Florian Heidel

Professor, Director and Chair

Hannover Medical School

GERMANY

View details

Giulia Ciotti

Istituto Oncologico Veneto

ITALY

View details

Francesco Cavazzini

associate professot

University of Ferrara

ITALY

View details

Francesco Buccisano

Associate Professor

UNIVERSITY TOR VERGATA

ITALY

View details

Anna Candoni

Docenti di ruolo di IIa fascia

University of Modena and Reggio Emilia

ITALY

View details

Giovanni Caocci

University of Cagliari

ITALY

View details

Maria Paola Martelli

University of Perugia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mario Tiribelli

Research Interests

Explore related searches

Articles (20)

Use of Peripheral Blood to Measure Residual Disease by Flow Cytometry in Adult Acute Myeloid Leukemia: Final Report of the Prospective GIMEMA AML1310 Trial

Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real‐Life Survey Within the Italian Chronic Myeloid Leukemia Network

Risk factors and reasons for switching from front‐line therapy in the Italian chronic myeloid leukaemia network: A cohort study

Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison

Survival and quality‐of‐life implications of cytopenia trajectories in ruxolitinib‐treated myelofibrosis

Revised “iRR6” model in intermediate‐1 risk myelofibrosis patients treated with ruxolitinib

Chronic myeloid leukemia outcomes according to baseline risk and first‐line treatment in real‐world settings: Data from the Italian Network/CML Campus

Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea

New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers

Monoclonal Antibodies Against Myeloid Leukemia Cells: Current Knowledge and Future Directions

CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?

ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?

Clinical outcomes of ruxolitinib treatment in 595 intermediate‐1 risk patients with myelofibrosis: The RUX‐MF Real‐World Study

Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy

Advancing Chimeric Antigen Receptor T-Cell Therapy for Acute Myeloid Leukemia: Current Limitations and Emerging Strategies

Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study

The Role of Allogeneic Transplantation in Chronic Myeloid Leukemia in 2023: A Case-Based Concise Review

Checkpoint Inhibitors in Acute Myeloid Leukemia

A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis

Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic‐phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML

Collaborators (16)

daniela cilloni

Daniela DAMIANI

Antonio Cuneo

Novella Pugliese

Valerio De Stefano

Massimiliano BONIFACIO

Francesca Palandri

elena rossi

Giuseppe Alberto Maria PALUMBO

Florian Heidel

Giulia Ciotti

Francesco Cavazzini

Francesco Buccisano

Anna Candoni

Giovanni Caocci

Maria Paola Martelli

Make your next move.